Prevalence and Association of Basal Ganglia Calcifications and Depressive Symptoms in Patients With Mild Cognitive Impairment or Dementia

Alzheimer Dis Assoc Disord. 2022 Oct-Dec;36(4):335-339. doi: 10.1097/WAD.0000000000000523. Epub 2022 Aug 15.

Abstract

Aim: The aim of this study is to investigate the association between basal ganglia calcification (BGC) and depressive symptoms within older adults with mild cognitive impairment (MCI) or dementia.

Methods: For this cross-sectional study, we included patients with MCI or dementia who visited the memory clinic between April 2009 and April 2015. All patients underwent a standard diagnostic workup, including assessment of depressive symptoms with the Geriatric Depression Scale and computed tomography imaging of the brain. Computed tomography scans were assessed for presence and severity of BGC. To analyse the association between BGC and depressive symptoms, binary logistic regression models were performed with adjustment for age, sex, cardiovascular risk factors, and cardiovascular diseases.

Results: In total, 1054 patients were included (median age: 81.0 y; 39% male). BGC was present in 44% of the patients, of which 20% was classified as mild, 20% as moderate, and 4% as severe. There were 223 patients (21%) who had a Geriatric Depression Scale score indicative of depressive symptoms. No association was found between the presence or severity of BGC and depressive symptoms.

Conclusions: Although both BGC and depressive symptoms were common in patients with MCI or dementia, no association was demonstrated between the presence or severity of BGC and depressive symptoms.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Basal Ganglia Diseases* / epidemiology
  • Basal Ganglia Diseases* / psychology
  • Calcinosis* / epidemiology
  • Calcinosis* / psychology
  • Cognitive Dysfunction* / epidemiology
  • Cross-Sectional Studies
  • Dementia* / epidemiology
  • Depression* / epidemiology
  • Female
  • Humans
  • Male
  • Prevalence
  • Risk Factors